Tokyo, Dec. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059750) titled 'Research toward realizing well-being through the utilization of human microbiome-related information' on Dec. 25.
Study Type:
Observational
Primary Sponsor:
Institute - Cykinso, Inc.
Condition:
Condition - Healthy volunteer
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Development of clinical screening methods that enable accurate and rapid detection of a great number of microorganisms
Development of mathematical analysis technique for understanding the relationship between lifestyle and microbiome
Development of personalized recommendations for the enhancing well-being
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Users of gut microbiome testing services (Mykinso), oral microbiota testing services (Mykinso Oral), and related services.
Subjects who receive a sufficient briefing of the objective and content of the present study, fully understand and agree to voluntarily participate in the study. Alternatively, subjects for whom consent can be obtained from a legally authorized representative capable of inferring the subject's will.
Key exclusion criteria - Subjects deemed unsuitable by the principal investigator
Target Size - 300000
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 10 Month 09 Day
Date of IRB - 2025 Year 10 Month 23 Day
Anticipated trial start date - 2025 Year 12 Month 18 Day
Last follow-up date - 2030 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068328
Disclaimer: Curated by HT Syndication.
